|
Press Releases |
|
|
|
Tuesday, July 26, 2016 |
|
Singapore-based Luye Medical Group Signs MOU with China's City of Chongqing for RMB2B Strategic Partnership |
Singapore-based Luye Medical Group, has signed a strategic cooperation memorandum of understanding (MOU) with Jiangbei District Government, Chongqing in China to introduce globally renowned healthcare knowledge and expertise into Chongqing and jointly develop healthcare capabilities and services in the city. more info >> |
|
Friday, May 6, 2016 |
|
Luye Medical welcomes Australia's Healthe Care to its Group |
Healthe Care, Australia's third largest private healthcare group, officially became a member of Luye Medicals Group Pte Ltd (Luye Medical Group) after the acquisition from Australia's Archer Capital Fund completed on April 18. more info >> |
|
Sunday, April 24, 2016 |
|
Singapore-based Luye Medical Group Completes Acquisition of Healthe Care, Australia's Third Largest Private Healthcare Group |
On April 18, 2016, Australia's third largest private healthcare group, Healthe Care, officially became a member of Luye Medicals Group Pte Ltd (Luye Medical Group) after the acquisition from Australia's Archer Capital Fund was completed. more info >> |
|
Friday, October 9, 2015 |
|
China's First Innovative Drug Led by Luye Pharma Approved NDA in the U.S. |
The leading innovative pharmaceutical company with strong R&D capability and global vision in China market-Luye Pharma Group Ltd. (the "Company", together with its subsidiaries, "Luye", stock code: 2186.HK), announced that the United States Food and Drug Administration (the "FDA") has confirmed that no additional clinical trials are needed for the New Drug Application ("NDA") submission for Risperidone Extended-release Microspheres for Injection ("LY03004") in the U.S. more info >> |
|
Wednesday, August 5, 2015 |
|
綠葉集團收購新加坡基因測序公司 進軍精準醫療領域 |
綠葉集團(簡稱「集團」),日前宣佈,收購新加坡基因測序公司Vela Diagnostics。 more info >> |
|
Thursday, May 14, 2015 |
|
Luye Pharma was Selected as a Constituent of The MSCI Global Standard Indexes- China Index |
A leading innovative pharmaceutical company with strong R&D capability and global vision in China market-Luye Pharma Group Ltd. (stock code: 2186.HK), is pleased to announce that the Group has been selected as a constituent of Morgan Stanley Capital International ("MSCI") China Index under MSCI Global Standard Indexes and will take effect as of market close on 29 May 2015.
more info >> |
|
Wednesday, April 1, 2015 |
|
Luye Announces 2014 Annual Results |
A leading innovative pharmaceutical company with strong R&D capability and global vision in China market-Luye Pharma Group Ltd., announced its annual results for the year ended 31 December 2014. more info >> |
|
|
|
|
|
|
|
|
Latest Press Releases |
|
MHI America Acquires Three Utility-Scale Solar Power Projects in Pennsylvania, Advancing the Company's Energy Transition Strategy
Jul 19, 2024 19:04 JST
|
|
|
Countdown to the first ever Thai innovation and startup network expo 'SITE 2024' at SCI Power For Future Thailand
Jul 19, 2024 18:00 HKT/SGT
|
|
|
每两名香港人有超过一人当义工 义工的幸福感高近三成
Jul 19, 2024 15:58 HKT/SGT
|
|
|
每兩名香港人有超過一人當義工 義工的幸福感高近三成
Jul 19, 2024 13:14 HKT/SGT
|
|
|
冠君产业信托首度举办「ESG周」
Jul 19, 2024 11:42 HKT/SGT
|
|
|
JCB and Worldline unveil a new whitepaper offering European merchants invaluable insights into facilitating seamless payments for international consumers
Jul 19, 2024 12:00 JST
|
|
|
富士通、フェイクニュースの社会課題を解決する偽情報対策システムの研究開発を加速
Jul 19, 2024 10:30: JST
|
|
|
Fujitsu Chosen to Help Solving Social Issues Caused by Fake News
Jul 19, 2024 11:30 JST
|
|
|
中港澳最大香水品牌管理公司穎通控股申請在港上市
Jul 18, 2024 23:30 HKT/SGT
|
|
|
中港澳最大香水品牌管理公司颖通控股申请在港上市
Jul 18, 2024 23:25 HKT/SGT
|
|
|
圓幣科技加入香港金融管理局穩定幣發行人「沙盒」 成為穩定幣創新先驅
Jul 18, 2024 23:06 HKT/SGT
|
|
|
RD Technologies Joins the HKMA Stablecoin Issuer Sandbox
Jul 18, 2024 22:59 HKT/SGT
|
|
|
OWIS Students Win Big at 10th SASMO Competition
Jul 18, 2024 21:00 HKT/SGT
|
|
|
Champion REIT holds first 'ESG Week'
Jul 18, 2024 20:14 JST
|
|
|
冠君產業信託首度舉辦「ESG週」
Jul 18, 2024 19:04 HKT/SGT
|
|
|
|
More News >> |
|
|
|
|
|